Basic information Brand Name(s) in US Veterinary fluoroquinolone antimicrobial agents Reasonable compatibility Incompatibility Side effects Precautions Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antibiotics >  Other antibiotic Drugs >  Enrofloxacin

Enrofloxacin

Basic information Brand Name(s) in US Veterinary fluoroquinolone antimicrobial agents Reasonable compatibility Incompatibility Side effects Precautions Uses Safety Supplier Related

Enrofloxacin Basic information

Product Name:
Enrofloxacin
Synonyms:
  • 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinoli
  • ROFLOXACIN BASE
  • enrofloxacin Baytril
  • Enorofloxacin hydrochloride
  • ENROFLOXACIN MM(CRM STANDARD)
  • ENROFLOXACIN 99%
  • EnrofloxacinBaseCpv2000
  • Enrofloxacine
CAS:
93106-60-6
MF:
C19H22FN3O3
MW:
359.39
EINECS:
618-911-2
Product Categories:
  • Veterinaries
  • Antibiotics for Research and Experimental Use
  • Biochemistry
  • Quinolones (Antibiotics for Research and Experimental Use)
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Heterocycles
  • API
  • BAYTRIL
  • Antibiosis
Mol File:
93106-60-6.mol
More
Less

Enrofloxacin Chemical Properties

Melting point:
225 °C
Boiling point:
560.5±50.0 °C(Predicted)
Density 
1.385±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,2-8°C
form 
powder or crystals
pka
6.43±0.41(Predicted)
Water Solubility 
Soluble in chloroform. Slightly soluble in water. Also soluble in dilute KOH
Merck 
14,3592
BRN 
5307824
CAS DataBase Reference
93106-60-6(CAS DataBase Reference)
EPA Substance Registry System
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo- (93106-60-6)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36/37-24/25
WGK Germany 
3
RTECS 
VB1993650
HS Code 
29339900
Hazardous Substances Data
93106-60-6(Hazardous Substances Data)
Toxicity
LD50 in male, female mice (mg/kg): >5000, 4336 orally; ~200, ~200 i.v.; in male rats, male rabbits (mg/kg): >5000, 500-800 orally (Altreuther)
More
Less

Enrofloxacin Usage And Synthesis

Brand Name(s) in US

Baytril

Veterinary fluoroquinolone antimicrobial agents

Enrofloxacin and sarafloxacin, danofloxacin, difloxacin, ofloxacin, norfloxacin, orbifloxacin are commonly used third-generation fluoroquinolone broad-spectrum antimicrobial agents in veterinary clinic at present , is ethyl compound of ciprofloxacin, also known as ethyl ciprofloxacin, ethyl ciprofloxacin, norfloxacin, is effective on Gram-negative bacteria, Gram-positive bacteria and mycoplasma, its antibacterial activity is significantly superior to norfloxacin, the effect on mycoplasma is stronger than tylosin and Tiamulin Fumarate. This product is oral, intramuscular and subcutaneous injection, and is easily absorbed, widely distributed in vivo, in addition to the central nervous system, the concentration of the drug in other organizations, almost all are higher than the blood concentration. De ethylation in vivo, mainly produced active metabolite ciprofloxacin, but different among the animals metabolism are larger, birds, dogs, rabbits and cattle body's metabolic rates are high, horses and pigs body's metabolic rates are lower. Clinically Enrofloxacin is used for the treatment of various mycoplasma disease, and respiratory system, digestive system and urogenital system infections, skin infections and sepsis caused by E. coli, Salmonella, Haemophilus, Erysipelas bacillus, Staphylococcus, Streptococcus etc. Especially suitable for mixing infections caused by a variety of bacteria.

Spatial structure formulae diagram of Enrofloxacin
The above information is edited by the chemicalbook of Liu Yujie.

Reasonable compatibility

1. Cooperated application of Enrofloxacin with aminoglycoside (gentamicin), third-generation cephalosporins (cefotaxime, ceftriaxone) and penicillin, colistin, may have synergistic antibacterial effect on certain bacteria (especially Pseudomonas aeruginosa or Enterobacteriaceae), in addition to penicillin-type drugs, due to enhanced toxicity, when in combination, need to reduce the dose, and administered separately.
2. Antibacterial activity of Enrofloxacin combined with apramycin enhanced, showed a synergistic effect. The reason was that antibacterial mechanism of apramycin was to specifically hinder biosynthesis of bacterial protein, and thus achieved effect on inhibiting and killing bacteria, while Enrofloxacin could specifically act on subunit A of bacterial DNA gyrase, inhibiting its activity, affecting DNA melting and sealing chain, both of combination had double blocking effect on bacterial replication and translation process.
3. at the same day were successively mixed to drink with colistin sulfate, can improve the efficacy of Enrofloxacin on chicken bacterial disease. and compatibility with SD silver used for the topical treatment of otitis in dogs.
Reference data: Zheng Hugong, Cui Yaoming editor. reasonable compatibility use of veterinary, Zhengzhou: Henan Science and Technology Press, 2009.

Incompatibility

1. Enrofloxacin can inhibit metabolism of theophylline and caffeine, make the blood concentration increase, thereby causing toxic reactions.
2. Combined with anticholinergic drugs (atropine, 654-2) and H2 receptor antagonists (cimetidine, famotidine), making the bioavailability of Enrofloxacin reduce.
3. Enrofloxacin has a role in inhibiting liver drug enzymes, in combination with drugs metabolized in the liver such as erythromycin, lincomycin, etc. making its clearance decrease, blood concentration increased.
4. antacids may reduce absorption of Enrofloxacin in the gastrointestinal tract, not suitable for simultaneous use.
5. mixed with strongly acidic liquid and the strong alkaline liquid and precipitated.
6. Enrofloxacin and metoclopramide occur chemical changes, easy to turn into muddy, should not be mixed injection.

Side effects

Toxicity of Enrofloxacin is less, safe for clinical use. Therapeutic doses have non-teratogenic and mutagenic effect. Can make young animals cartilage occur turbid, causing lameness and pain. Digestive system reactions are vomiting, abdominal pain and bloating. Skin reactions are erythema, pruritus, urticaria and photosensitivity reactions, etc.

Precautions

1. Enrofloxacin aqueous solution was met with light and easy to change color and decompose, should be kept in dark place.
2. Drug-resistant strains of the product showed an increasing trend, not used at sub-therapeutic doses for long-term.
3. Antacids can inhibit the absorption of this product, should be avoided drinking at the same time.
4. In clinical application, can appropriately adjust dosage based on disease, concentration range of drinking water in poultry, per liter of water, added 25 to 100 mg.
5. withdrawal period of chicken is 8 days. Disabled in egg producing period of laying hen.
6. chicks are very sensitive to Enrofloxacin injection, had many poisoning report, the dose should be strictly controlled.

Uses

1. Antimicrobial, for bacteria and mycoplasma infection.
2. New veterinary antimicrobial drugs, broad-spectrum, high efficiency, has special effects on Gram-positive and Gram-negative bacteria and mycoplasma.

Chemical Properties

Pale Yellow Crystals

Uses

Fluorinated quinolone antibacterial

Definition

ChEBI: A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid substituted by an oxo group at position 4, a fluoro group at position 6, a cyclopropyl group at position 1 and a 4-ethylpiperazin-1-yl group at position 7. It is a veterinary ant bacterial agent used for the treatment of pets.

brand name

Baytril (Bayer).

Veterinary Drugs and Treatments

Enrofloxacin is approved for use in dogs and cats (oral only) for the management of diseases associated with bacteria susceptible to enrofloxacin. Because of the dosage restriction (5 mg/kg) for cats, enrofloxacin is generally used in this species only for the most susceptible bacterial infections. It is also been approved for use in cattle (not dairy cattle or veal calves).

Enrofloxacin Preparation Products And Raw materials

Raw materials

EnrofloxacinSupplier

Wuhan Yuqing Jiaheng Pharmaceutical Co., Ltd Gold
Tel
027-83855382-
Email
15926260338@163.com
Wuhan Dingtong Pharmaceutical Co., Ltd Gold
Tel
027-59207795-
Email
18327179646@163.com
Wuhan Dingxintong Pharmaceutical Co. , Ltd. Gold
Tel
027-83984790-
Email
t17720532645@163.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Mr Qiu:021-50182298(Demestic market) Miss Xu:021-50180596(Abroad market)
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
010-82848833- ;010-82848833-
Email
jkinfo@jkchemical.com;market6@jkchemical.com